Antidepressant medication and ocular factors in association with the need for anti-VEGF retreatment in neovascular age-related macular degeneration

BACKGROUND/AIMS: Vascular endothelial growth factor (VEGF) is a key player in the pathogenesis of neovascular age-related macular degeneration (nAMD) and is also involved in the final common pathway of antidepressant medication. This study investigated the relationship between the need for anti-VEGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantel, Irmela, Zola, Marta, Mir, Olivier, Gaillard, Raphael, Behar-Cohen, Francine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582817/
https://www.ncbi.nlm.nih.gov/pubmed/30030393
http://dx.doi.org/10.1136/bjophthalmol-2018-312318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582817/
https://www.ncbi.nlm.nih.gov/pubmed/30030393
http://dx.doi.org/10.1136/bjophthalmol-2018-312318

Ejemplares similares